Linqiang Ma

1.9k total citations
29 papers, 671 citations indexed

About

Linqiang Ma is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Linqiang Ma has authored 29 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Linqiang Ma's work include Hormonal Regulation and Hypertension (17 papers), Adrenal and Paraganglionic Tumors (11 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers). Linqiang Ma is often cited by papers focused on Hormonal Regulation and Hypertension (17 papers), Adrenal and Paraganglionic Tumors (11 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (6 papers). Linqiang Ma collaborates with scholars based in China, Australia and United States. Linqiang Ma's co-authors include Jinbo Hu, Qifu Li, Shumin Yang, Zhihong Wang, Ting Luo, Ying Song, Wenwen He, Chuan Peng, Yi Yang and Hua Qing and has published in prestigious journals such as Hepatology, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Linqiang Ma

27 papers receiving 666 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linqiang Ma China 15 298 255 211 118 91 29 671
Xiang Hu China 14 157 0.5× 187 0.7× 257 1.2× 163 1.4× 64 0.7× 32 615
Komuraiah Myakala United States 9 272 0.9× 185 0.7× 180 0.9× 85 0.7× 217 2.4× 18 580
Liru Qiu China 11 229 0.8× 209 0.8× 236 1.1× 79 0.7× 245 2.7× 32 712
Jinshan Wu China 11 153 0.5× 77 0.3× 145 0.7× 89 0.8× 140 1.5× 16 515
S-L Wang China 8 179 0.6× 95 0.4× 96 0.5× 69 0.6× 64 0.7× 26 513
Hyun Wha Chung South Korea 9 214 0.7× 128 0.5× 227 1.1× 77 0.7× 139 1.5× 13 574
Thomas Hach Germany 15 827 2.8× 436 1.7× 506 2.4× 76 0.6× 84 0.9× 38 1.2k
Xiaoni Liu China 11 600 2.0× 355 1.4× 319 1.5× 63 0.5× 93 1.0× 21 803
Amanda Mather Australia 8 506 1.7× 270 1.1× 274 1.3× 49 0.4× 234 2.6× 22 804
Tamara Glavinovic Canada 7 210 0.7× 295 1.2× 69 0.3× 57 0.5× 38 0.4× 13 552

Countries citing papers authored by Linqiang Ma

Since Specialization
Citations

This map shows the geographic impact of Linqiang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linqiang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linqiang Ma more than expected).

Fields of papers citing papers by Linqiang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linqiang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linqiang Ma. The network helps show where Linqiang Ma may publish in the future.

Co-authorship network of co-authors of Linqiang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Linqiang Ma. A scholar is included among the top collaborators of Linqiang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linqiang Ma. Linqiang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lei, Jing, Yue Wang, Ying Song, et al.. (2025). A novel nonsense mutation of the glucocorticoid receptor gene causing glucocorticoid resistance with infertility. Endocrine. 89(3). 879–890.
2.
Shen, Hang, Jinbo Hu, Jun Yang, et al.. (2024). Comparison of four confirmatory tests for the diagnosis of primary aldosteronism: Bayesian analysis in the absence of a gold standard. Endocrine. 85(3). 1417–1424. 2 indexed citations
3.
Luo, Xiaolin, Xiangjun Chen, Ruolin Li, et al.. (2024). Renin-independent aldosteronism and metabolic dysfunction-associated steatotic liver disease and cirrhosis: A genetic association study. Clinical Nutrition. 44. 193–200. 2 indexed citations
4.
Ma, Linqiang, Chuan Peng, Ping Wang, et al.. (2024). Neutrophil extracellular traps promote macrophage inflammation in psoriasis. Clinical Immunology. 266. 110308–110308. 11 indexed citations
5.
Gong, Lilin, Xiangjun Chen, Rufei Gao, et al.. (2022). Lifestyle and chronic kidney disease: A machine learning modeling study. Frontiers in Nutrition. 9. 918576–918576. 14 indexed citations
6.
Kang, Bing, Chuan Peng, Kanran Wang, et al.. (2022). Elevated Myoglobin in Patients With Primary Aldosteronism: A Cross-Sectional Study. Frontiers in Endocrinology. 13. 799174–799174. 1 indexed citations
7.
Hu, Jinbo, Qingfeng Cheng, Ying Jing, et al.. (2021). Comparison of Bolus and Continuous Infusion of Adrenocorticotropic Hormone During Adrenal Vein Sampling. Frontiers in Endocrinology. 12. 784706–784706. 7 indexed citations
8.
Wu, Jinshan, Zeguo Sun, Shumin Yang, et al.. (2021). Kidney single-cell transcriptome profile reveals distinct response of proximal tubule cells to SGLT2i and ARB treatment in diabetic mice. Molecular Therapy. 30(4). 1741–1753. 40 indexed citations
9.
Wang, Yue, Jinbo Hu, Ting Luo, et al.. (2021). Low‐dose colchicine in type 2 diabetes with microalbuminuria: A double‐blind randomized clinical trial. Journal of Diabetes. 13(10). 827–836. 13 indexed citations
10.
Hu, Jinbo, Hang Shen, Jun Yang, et al.. (2021). Heightened Cardiovascular Risk in Hypertension Associated With Renin‐Independent Aldosteronism Versus Renin‐Dependent Aldosteronism: A Collaborative Study. Journal of the American Heart Association. 10(24). e023082–e023082. 29 indexed citations
11.
12.
Yang, Yi, Tracy Ann Williams, Ying Song, et al.. (2020). Nomogram-Based Preoperative Score for Predicting Clinical Outcome in Unilateral Primary Aldosteronism. The Journal of Clinical Endocrinology & Metabolism. 105(12). e4382–e4392. 23 indexed citations
13.
He, Wenwen, Linqiang Ma, Ying Song, et al.. (2020). Primary aldosteronism in young adults with acute stroke: Prevalence and clinical characteristics. Journal of the Neurological Sciences. 413. 116774–116774. 8 indexed citations
14.
Yang, Yi, Ming Xiao, Ying Song, et al.. (2019). H-score of 11β-hydroxylase and aldosterone synthase in the histopathological diagnosis of adrenocortical tumors. Endocrine. 65(3). 683–691. 24 indexed citations
15.
Hu, Jinbo, Chuan Peng, Jiayu Li, et al.. (2018). Serum Bisphenol A is an independent risk factor of hyperuricemia: A 6-year prospective study. Seminars in Arthritis and Rheumatism. 48(4). 644–648. 14 indexed citations
16.
Shu, Xiaoyu, Mei Mei, Linqiang Ma, et al.. (2018). Postmenopausal osteoporosis is associated with elevated aldosterone/renin ratio. Journal of Human Hypertension. 32(7). 524–530. 13 indexed citations
17.
Pei, Ya, Honggui Li, Yuli Cai, et al.. (2018). Regulation of adipose tissue inflammation by adenosine 2A receptor in obese mice. Journal of Endocrinology. 239(3). 365–376. 26 indexed citations
18.
Ma, Linqiang, Jinbo Hu, Jiayu Li, et al.. (2017). Bisphenol A promotes hyperuricemia via activating xanthine oxidase. The FASEB Journal. 32(2). 1007–1016. 37 indexed citations
19.
Song, Ying, Shumin Yang, Wenwen He, et al.. (2017). Confirmatory Tests for the Diagnosis of Primary Aldosteronism. Hypertension. 71(1). 118–124. 86 indexed citations
20.
Chen, Xuemei, Huizhe Huang, Hua Wang, et al.. (2014). Characterization of Zebrafish Pax1b and Pax9 in Fin Bud Development. BioMed Research International. 2014. 1–11. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiang Hu Breakdown of academic impact, for papers by Komuraiah Myakala Breakdown of academic impact, for papers by Liru Qiu Breakdown of academic impact, for papers by Jinshan Wu Breakdown of academic impact, for papers by S-L Wang Breakdown of academic impact, for papers by Hyun Wha Chung Breakdown of academic impact, for papers by Thomas Hach Breakdown of academic impact, for papers by Xiaoni Liu Breakdown of academic impact, for papers by Amanda Mather Breakdown of academic impact, for papers by Tamara Glavinovic
Rankless by CCL
2026